Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Archives of Pediatrics & Adolescent Medicine|September 7, 2011
Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosisMiriam M Treggiari, George Retsch-Bogart, Nicole Mayer-Hamblett, et al.American Journal of Respiratory and Critical Care Medicine|December 14, 2002
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosisRonald L Gibson, Julia Emerson, Sharon McNamara, et al.Annals of the American Thoracic Society|January 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study DesignNicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2014
Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosisNicole Mayer-Hamblett, Bonnie W Ramsey, Hemantha D Kulasekara, et al.The European Respiratory Journal|February 5, 2021
Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosisSanja Stanojevic, Stephanie D Davis, Lucy Perrem, et al.American Journal of Respiratory and Critical Care Medicine|June 2, 2025
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A 192-Week, Phase 3, Open-Label Extension StudyClaire Wainwright, Susanna A McColley, Paul McNally, et al.Thorax|October 28, 2021
Testing the effects of combining azithromycin with inhaled tobramycin for <i>P. aeruginosa</i> in cystic fibrosis: a randomised, controlled clinical trialDavid P Nichols, Pradeep K Singh, Arthur Baines, et al.The European Respiratory Journal|November 18, 2017
Airway microbiota across age and disease spectrum in cystic fibrosisEdith T Zemanick, Brandie D Wagner, Charles E Robertson, et al.American Journal of Respiratory and Critical Care Medicine|May 2, 2015
Official American Thoracic Society technical standards: flexible airway endoscopy in childrenAlbert Faro, Robert E Wood, Michael S Schechter, et al.The Lancet. Respiratory Medicine|November 7, 2022
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsNicole Mayer-Hamblett, Felix Ratjen, Renee Russell, et al.Pageof 4